MAPK8 and breast cancer: Intriguingly, the JNK inhibitor AS602801, bentamapimod, was evidenced to block gap-junction communication between astrocytes and glioma cells [53], lung cancer stem cells [54], and breast cancer cells, and together with modulating Cx43 expression, it inhibited particular cancer metastasis to the brain [24].